- Home
- FLNA vs XGN Comparison
FLNA vs XGN Comparison
Compare FLNA & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLNA | XGN |
|---|---|---|
| Founded | 1998 | 2002 |
| Country | United States | United States |
| Employees | 20 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 71.2M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | FLNA | XGN |
|---|---|---|
| Price | $1.25 | $4.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $8.86 |
| AVG Volume (30 Days) | 346.0K | ★ 401.9K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.12 |
| Revenue Next Year | N/A | $13.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.16 | $2.59 |
| 52 Week High | $2.03 | $12.23 |
Technical Indicators
Market Signals| Indicator | FLNA | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 40.61 | 57.89 |
| Support Level | $1.16 | $2.68 |
| Resistance Level | $1.80 | $5.55 |
| Average True Range (ATR) | 0.10 | 0.42 |
| MACD | -0.00 | -0.07 |
| Stochastic Oscillator | 4.41 | 36.81 |
Price Performance
Historical ComparisonAbout FLNA Filana Therapeutics Inc. Common Stock
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
About XGN Exagen Inc.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.